Research and Diagnostic Samples are defined in the Regulation (EU) 142/2011 as ‘animal by-products and derived products (ABPs) intended for examination in the context of diagnostic activities or analysis for the promotion of progress in science and technology, in the context of education or research activities. They also must:
be imported in accordance with the requirements laid down in Regulation (EU) 142/2011
have been authorised by the competent authority of the country of destination
Any subsequent use of research and diagnostic samples for purposes other than those referred to above shall be prohibited. They cannot for example be used for commercial use.
At this moment, there is no requirement for consignment of Research and Diagnostic samples from the EU and European Free Trade Association (EFTA) countries (Iceland · Liechtenstein · Norway · Switzerland) to be accompanied by an import authorisation or facilitation letter. However, as from 1st February 2025, this changes with consignments having to be accompanied by a general import authorisation, a form that will be available soon at Gov.uk
This general authorisation can be used for any product that meets the definition of ‘research and diagnostic sample’ and can comply with the conditions for import as set out in this import information note.
Traders will no longer need to apply to APHA for a specific import authorisation to import research and diagnostic samples from the EU and EFTA member states, instead they will simply be required to obtain an authorisation from Gov.uk
Here's other things UK importers need to be aware of:
1. Health Certification Requirements: For medium and high-risk animal by-products (ABPs) used in research and diagnostics, importers must provide an official health certificate or a commercial document if no health certificate is applicable. These documents must confirm the safety and origin of the samples
2. Pre-Notification and Documentation: All imports need to be pre-notified using the IPAFFS system. For certain samples categorized as low risk under the Border Target Operating Model (BTOM), simpler documentation like a commercial document may suffice. This categorization is based on the product's processing level and disease transmission risk
3. Approved Establishments: Samples must originate from EU or EFTA facilities approved to export to GB. Importers should verify the establishment's status on official listings to avoid delays at border inspections.
4. Physical Inspections: Increased physical checks will be introduced for certain sample types, focusing on medium and high-risk imports. Ensuring accurate paperwork will expedite border clearance.
Businesses involved in importing research or diagnostic materials should familiarize themselves with these requirements and prepare early to avoid disruptions. For detailed guidance, refer to resources like the UK government's animal by-products import page.
Importing Help
If you require support with the importing of Research and Diagnostic samples, feel free to drop our team an email asking for support. From importing training to documentation or customs clearance and compliance advice, our team is at hand to support. Call us at 0161 393 4314 or email us at international@gmchamber.co.uk
Source: Merseyside Port Health Authority, Gov.uk
Comments